Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

NICE Recommends Praluent, Repatha for Treating Cholesterol

May 6, 2016 12:55 pm | News | Comments

The draft guidance recommends the drugs, which are not licensed for everyone who has high cholesterol levels, only if they are provided at the discounted price agreed with the companies.

TOPICS:

Long-Term Warfarin Use for AF Linked to Dementia Risk

May 6, 2016 12:10 pm | by Stephanie Guzowski, Editor | News | Comments

Patients with the heart rhythm disorder atrial fibrillation (AF) who were treated long term with the blood thinner, warfarin, may have higher rates of dementia, according to a recent study of more than 10,000 patients.

TOPICS:

Allergan Receives FDA Approval to Launch First Generic Version of Crestor

May 6, 2016 9:34 am | News | Comments

Allergan is the first company to launch a generic version of of this drug to customers in the U.S.

TOPICS:
Advertisement

Newly Revealed Epigenome Complexity Offers Clues for Regulatory Function

May 6, 2016 9:29 am | by Jonas Korlach, Chief Scientific Officer, PacBio | Articles | Comments

In recent years, it has become clear that the impact of epigenetics is more common and complex than previously suspected, underscoring the need to conduct in-depth studies of these mechanisms.

TOPICS:

Medivation: No to Sanofi's Renewed Press to Take $9.3B Offer

May 6, 2016 9:24 am | by Linda A. Johnson, AP Business Writer | News | Comments

The swift response came hours after Paris-based Sanofi, France's biggest drugmaker, threatened Medivation's board members with possible removal if they won't discuss a deal.

TOPICS:

Popular Heartburn Drugs May Cause Serious Kidney Damage

May 6, 2016 9:04 am | by Washington University in St. Louis | News | Comments

More than 15 million Americans have prescriptions for so-called proton pump inhibitors (PPIs), which decrease gastric acid production and generally have been considered safe.

TOPICS:

Scripps Florida Awarded $2.5M to Advance Development of RNA-Based Therapeutics

May 6, 2016 8:51 am | by TSRI | News | Comments

The new grant will enable Disney and his team to further investigate the manipulation of microRNAs.

TOPICS:

Researchers Find Alternative Pathways to HIV Antibodies

May 6, 2016 8:28 am | by Duke University | News | Comments

The immune system appears to hamper an investigational vaccine from inducing antibodies that protect against HIV infection.

TOPICS:
Advertisement

Eli Lilly Granted Priority Review for Soft Tissue Sarcoma Drug

May 6, 2016 8:27 am | News | Comments

Lilly has received additional designations for olaratumab from the FDA.

TOPICS:

Research Suggests Diabetes Drug Acts Differently from Previous Theories

May 6, 2016 8:00 am | by Mayo Clinic | News | Comments

Metformin's action is generally related to the release of glucose from the liver.

TOPICS:

Scientists Use Microbes, Methane to Create Sustainable Omega 3

May 5, 2016 4:00 pm | by University of Nottingham | News | Comments

Scientists are trying to find new ways to produce the nutritional fatty acids.

TOPICS:

Novel Disease Model Developed to Study Multiple Myeloma

May 5, 2016 3:00 pm | by University of Miami School of Medicine | News | Comments

Multiple myeloma affects more than 30,000 Americans each year and is slightly more prevalent in men than in women.

TOPICS:

Gene Replacement Therapy Offers Viable Treatment Option for Fatal Disease

May 5, 2016 2:00 pm | by University of Missouri-Columbia | News | Comments

The therapy has the ability to cross the blood-brain barrier and directly targets motor neurons affected by SMARD1.

TOPICS:

FDA Brings E-Cigarettes Under Federal Authority

May 5, 2016 1:00 pm | by Matthew Perrone, AP Health Writer | News | Comments

New federal rules announced Thursday have the potential to upend the multibillion-dollar electronic cigarette industry.

TOPICS:

Timed-Release Glaucoma Drug Insert as Alternative to Daily Drops

May 5, 2016 9:40 am | by American Academy of Ophthalmology | News | Comments

A new device that slowly releases eye medication may one day be a promising option for the many glaucoma patients who struggle with administering their own daily prescription eye drops.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading